Login / Signup

Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales.

Rochelle KnightVenexia M WalkerSamantha IpJennifer A CooperThomas BoltonSpencer J KeeneRachel DenholmAshley AkbariHoda AbbasizanjaniFatemeh TorabiEfosa OmigieSam HollingsTeri-Louise NorthRenin TomsXiyun JiangEmanuele Di AngelantonioSpiros DenaxasJohan H ThygesenChristopher TomlinsonBen BrayCraig J SmithMark BarberKamlesh KhuntiGeorge Davey SmithNishi ChaturvediCathie L M SudlowWilliam N WhiteleyAngela M WoodJonathan A C Sternenull null
Published in: Circulation (2022)
High relative incidence of vascular events soon after COVID-19 diagnosis declines more rapidly for arterial thromboses than VTEs. However, incidence remains elevated up to 49 weeks after COVID-19 diagnosis. These results support policies to prevent severe COVID-19 by means of COVID-19 vaccines, early review after discharge, risk factor control, and use of secondary preventive agents in high-risk patients.
Keyphrases
  • coronavirus disease
  • sars cov
  • risk factors
  • end stage renal disease
  • public health
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • gestational age